ABSTRACT. Babies with chronic bronchopulmonary dysplasia (BPD) can sometimes develop pallor, systemic and pulmonary edema, oliguria, and hyponatremia not attributable to cardiopulmonary or renal impairment. These signs and symptoms might, however, be explained by inappropriate control of vasopressin secretion. To test this hypothesis, we measured plasma vasopressin and osmolality, serum sodium and potassium concentrations, urine output and osmolality, and free water clearance in 26 normoxic infants with BPD aged 1-4 months. All of these infants required supplemental oxygen (FiOz 0.41 2 0.03, mean -C 1 S E ) to maintain O 2 saturation of >88%, and six infants also required mechanical ventilation. As controls, 1 0 infants of similar age but without B P D were also studied. None of the infants had been discharged from the nursery and was receiving any medications, and all were clinically stable when studied. Compared to control infants, infants with BPD had significantly elevated plasma vasopressin concentrations (control 5.2 2 0.9 pg/ml; BPD 42.4 k 5.1; mean k SE, p < 0.05). Moreover, infants with B P D had hyponatremia and hypotonic plasma, and both urine output and free water clearance were significantly reduced. These data suggest that some infants with chronic BPD have elevated vasopressin levels that are functionally significant. W e speculate that excessive stimulation of vasopressin secretion may explain some of the pulmonary and nonpulmonary signs and symptoms in infants with chronic BPD. (Pediatr Res 23: 86-88,1988) Abbreviations BPD, bronchopulmonary dysplasia ADH, antidiuretic hormone CPAP, continuous positive airway pressure FiOz, inspired oxygen concentration PaC02, arterial P C 0 2 tension Babies with chronic BPD can sometimes develop systemic and pulmonary edema, oliguria, hyponatremia, and hypertension that cannot be attributed to chronic congestive heart failure or to renal disease. In some infants with BPD, treatment with diuretics has resulted in improvement in lung function and in systemic edema (1, 2). Some of these signs and symptoms are
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MATERIALS AND METHODS
Study protocol. Thirty-six hospitalized premature infants were the subjects of this study. They were separated into two groups ( Table 1 ). The diagnosis of BPD was made by three criteria: 1) history of respiratory failure at birth which required mechanical ventilation and oxygen therapy, 2) evidence of pulmonary parenchymal disease on a chest radiograph at 28 days of age, and 3) continuous oxygen therapy still necessary beyond age 28 days to maintain O2 saturation at >88%. As shown in Table 1 ,26 infants met this criteria and were all oxygen dependent on the day they were studied.
Ten premature infants of similar age but without BPD were also studied as controls. These infants, like the infants with chronic BPD, had never been discharged from the nursery, and were receiving no medications other than vitamins. One control infant was receiving CPAP via nasal prongs and 23% oxygen for the treatment of apnea of prematurity, but had had no apnea for 72 h prior to the start of the study.
Infants were eligible for study if they were not receiving antibiotics, diuretics, P-agonist drugs, or corticosteroids. Infants with BPD were eligible if they had no evidence of deteriorating respiratory status; i.e. if changes in body weight did not exceed 30 g/kg/day, and if fluid/electrolyte or oxygen management were unchanged for 2 days before and after the study day. All but three infants received Similac Special Care Formula (Ross Laboratories, Columbus, OH), 24 kcal/oz, at rates of 120-1 50 ml/ kg/day, without other additives or salt supplements. The other three infants (two controls, one infant with BPD) received their mother's breast milk. Intraventricular hemorrhage was identified using the ultrasound technique and graded according to the 2 SDs above it, then this upper limit would be equal to 10.8 pg/ ml. Twenty-one of the 26 (80%) infants with BPD had a vasopressin level above this value. Moreover, although the number of ventilated infants is small, these high levels cannot be explained by the presence of positive airway pressures, or by mechanical ventilation; these factors may increase vasopressin secretion in newborn infants (1 3-16) . These data extend the observations of Rao et al. (17) who found elevated vasopressin levels in 12 infants with BPD who were rehospitalized for acute severe respiratory failure. In their study, hyponatremia was rare despite high vasopressin levels, suggesting that these acutely sick infants may have been in a nonsteady state in terms of their water balance. As a result, the physiologic importance of the high vasopressin concentrations in more stable infants with chronic BPD was not examined in their report.
Babies with BPD and chronic respiratory distress are characterized by cardiorespiratory instability, and some investigators believe that steady-state measurement of most physiologic functions is impossible in this group of infants. Our criteria for cardiorespiratory stability were strict; we required that waterelectrolyte balance and oxygen therapy be stable for several days before and after the measurement of fluid balance variables.
Although these data suggest a causal link between chronic lung diseases and high vasopressin levels, these two factors cannot be unequivocally correlated because lung function was not measured in all infants and other hormones known to affect fluid and electrolyte balance were not obtained. What are the possible explanations for elevated vasopressin concentrations in babies with chronic BPD? All of these infants were oxygen dependent but not hypoxemic, and all had pulmonary abnormalities visible on the chest radiograph, suggesting that some feature of their chronic lung disease was responsible. Nevertheless, we could not correlate the plasma vasopressin concentration with either FI02, or the PO2 and PCOz tension in arterial blood. We did not measure lung mechanics, functional residual capacity, or expiratory flow/volume relationships, and it is possible that these variables may correlate better with vasopressin secretion.
It is possible that these infants with chronic BPD may have had chronic congestive heart failure, which is associated with elevated vasopressin secretion (4). The BPD infants in this study did not have the classic clinical findings of chronic congestive heart failure, and this syndrome is not a common feature of adequately treated chronic BPD. Nevertheless, we cannot rule out the possibility that cardiac dysfunction was present which could not be detected clinically.
Dehydration increases vasopressin secretion but it is unlikely that the infants with BPD were dehydrated, since as shown in Table 3 , fluid intake did not differ from that of the control group. Elevated vasopressin levels could also be explained by a central defect of osmotic regulation, as seen in patients with head trauma (1 5), or in infants with acute intracerebral hemorrhage (1 6), but intracranial hemorrhage was just as frequent in both groups.
Other explanations for vasopressin excess in these patients might be release of vasopressin from the damaged developing lung or stimulation of vasopressin release by other endogenous stimuli. Vasopressin can be found in pulmonary small cell lung carcinoma of humans (1 8) . In addition, atrial natriuretic factor, hypoxia, undefined stresses, catecholamines, and other factors may also influence vasopressin secretion, but their physiologic effects in patients with chronic lung disease has not yet been reported (3, 4) .
Although many factors control water and electrolyte balance in humans, only two, vasopressin and atrial natriuretic peptide are secreted due to stimulation of intrathoracic mechanoreceptors (3, 19) . It is therefore possible that the elevated vasopressin concentrations resulted from abnormal transmural pressure gradients either in the heart, great vessels, or lungs of infants with chronic BPD; this mechanism has been hypothesized by others (6-8) but remains unproven.
In summary, we found that, for reasons yet unknown, some infants with chronic BPD have elevated vasopressin levels, which can cause hyponatremia and oliguria. This abnormality of water balance may explain some of the nonpulmonary signs and symptoms in infants with chronic BPD, and may explain why some infants with chronic BPD can have improved lung function when treated with diuretics (6, 20) .
